Tyler N. A. Winkelman

Tyler N. A. Winkelman

Auto-generated profile, based on publicly available information

Tyler N. A. Winkelman

Health, Homelessness, and Criminal Justice Lab, Hennepin Healthcare Research Institute, Minneapolis, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Pediatrics
Verified
Journal Article
Closed access
PDF file
TWTyler N.A. Winkelman
Tyler N.A. Winkelman
NVNicole Villapiano
Nicole Villapiano
KKKaty B. Kozhimannil
Katy B. Kozhimannil
MDMatthew M. Davis
Matthew M. Davis
SPStephen W. Patrick
Stephen W. Patrick
OBJECTIVES: To describe incidence, health care use, and cost trends for infants with neonatal abstinence syndrome (NAS) who are covered by Medicaid compared with other infants. METHODS: We used 2004–2014 hospital birth data from the National Inpatient Sample, a nationally representative sample of hospital discharges in the United States (N = 13 102 793). Characteristics and trends among births impacted by NAS were examined by using univariate statistics and logistic regression. RESULTS: Medicaid covered 73.7% of NAS-related births in 2004 (95% confidence interval [CI], 68.9%–77.9%) and 82.0% of NAS-related births in 2014 (95% CI, 80.5%–83.5%). Among infants covered by Medicaid, NAS incidence increased more than fivefold during our study period, from 2.8 per 1000 births (95% CI, 2.1–3.6) in 2004 to 14.4 per 1000 births (95% CI, 12.9–15.8) in 2014. Infants with NAS who were covered by Medicaid were significantly more likely to be transferred to another hospital and have a longer length of stay than infants without NAS who were enrolled in Medicaid or infants with NAS who were covered by private insurance. Adjusting for inflation, total hospital costs for NAS births that were covered by Medicaid increased from $65.4 million in 2004 to $462 million in 2014. The proportion of neonatal hospital costs due to NAS increased from 1.6% in 2004 to 6.7% in 2014 among births that were covered by Medicaid. CONCLUSIONS: The number of Medicaid-financed births that are impacted by NAS has risen substantially and totaled $462 million in hospital costs in 2014. Improving affordable health insurance coverage for low-income women before pregnancy would expand access to substance use disorder treatment and could reduce NAS-related morbidity and costs.

1 November 2018 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
LALindsay K. Admon
Lindsay K. Admon
TWTyler N. A. Winkelman
Tyler N. A. Winkelman
KZKara Zivin
Kara Zivin
MTMishka Terplan
Mishka Terplan
JMJill M. Mhyre
Jill M. Mhyre
VDVanessa K. Dalton
Vanessa K. Dalton
OBJECTIVE: To describe racial and ethnic disparities in the incidence of severe maternal morbidity during delivery hospitalizations in the United States. METHODS: We conducted a pooled, cross-sectional analysis of 2012–2015 data from the National Inpatient Sample to define the prevalence of chronic conditions and incidence of severe maternal morbidity among deliveries to non-Hispanic white, non-Hispanic black, Hispanic, Asian or Pacific Islander, and Native American or Alaska Native women. We used weighted multivariable logistic regression and predictive margins to generate prevalence and incidence estimates. Adjusted rate ratios and differences were calculated to quantify disparities across racial and ethnic categories. Subgroup analyses were performed to examine the incidence of severe maternal morbidity among deliveries to women with comorbid physical health conditions, behavioral health conditions, and multiple chronic conditions within each racial and ethnic category. RESULTS: The incidence of severe maternal morbidity was significantly higher among deliveries to women in every racial and ethnic minority category compared with deliveries among non-Hispanic white women. Severe maternal morbidity occurred in 231.1 (95% CI 223.6–238.5) and 139.2 (95% CI 136.4–142.0) per 10,000 delivery hospitalizations among non-Hispanic black and non-Hispanic white women, respectively ( P <.001). When excluding cases in which blood transfusion was the only indicator of severe maternal morbidity, only deliveries to non-Hispanic black women had a higher incidence of severe maternal morbidity compared with deliveries among non-Hispanic white women: 50.2 (95% CI 47.6–52.9) and 40.9 (95% CI 39.6–42.3) per 10,000 delivery hospitalizations, respectively (risk ratio 1.2 [95% CI 1.2–1.3], risk difference 9.3 [95% CI 6.5–12.2] per 10,000 delivery hospitalizations; P <.001 for each comparison). Among deliveries to women with comorbid physical and behavioral health conditions, significant differences in severe maternal morbidity were identified among racial and ethnic minority compared with non-Hispanic white women and the largest disparities were identified among women with multiple chronic conditions. CONCLUSION: Programs for reducing racial and ethnic disparities in severe maternal morbidity may have the greatest effect focusing on women at highest risk for blood transfusion and maternity care management for women with comorbid chronic conditions, particularly multiple chronic conditions.

6 July 2018 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TWTyler N.A. Winkelman
Tyler N.A. Winkelman
VCVirginia W. Chang
Virginia W. Chang
IBIngrid A. Binswanger
Ingrid A. Binswanger
In 2016, one person died from a drug overdose in the United States every 9 minutes on average.1 Rising drug deaths are being driven by large increases in opioid-related overdoses. With more than 1 in 3 US adults reporting use of prescription opioids (ie, use of prescription opioids that were obtained legally or illegally), the opioid epidemic is now a national public health emergency,2,3 and a public health approach is required to address the crisis.4,5

1 December 2017 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
LALindsay K. Admon
Lindsay K. Admon
TWTyler N. A. Md Winkelman
Tyler N. A. Md Winkelman
MMMichelle H. Md Moniz
Michelle H. Md Moniz
MDMatthew M. Md Davis
Matthew M. Md Davis
MHMichele Md Heisler
Michele Md Heisler
VDVanessa K. Dalton
Vanessa K. Dalton
OBJECTIVE: To estimate trends in the prevalence and socioeconomic distribution of chronic conditions among women hospitalized for obstetric delivery in the United States. METHODS: A retrospective, serial cross-sectional analysis was conducted using 2005–2014 data from the National Inpatient Sample. We estimated the prevalence of eight common, chronic conditions, each associated with obstetric morbidity and mortality, among all childbearing women and then across socioeconomic predictors of obstetric outcomes. Differences over time were measured and compared across rural and urban residence, income, and payer subgroups for each condition. RESULTS: We identified 8,193,707 delivery hospitalizations, representing 39,273,417 delivery hospitalizations occurring nationally between 2005 and 2014. Identification of at least one chronic condition increased significantly between 2005–2006 and 2013–2014 (66.9 per 1,000 delivery hospitalizations in 2005–2006 compared with 91.8 per 1,000 delivery hospitalizations in 2013–2014). The prevalence of multiple chronic conditions also increased during the study period, from 4.7 (95% CI 4.2–5.2) to 8.1 (95% CI 7.8–8.4) per 1,000 delivery hospitalizations between 2005–2006 and 2013–2014. Chronic respiratory disease, chronic hypertension, substance use disorders, and pre-existing diabetes were the disorders with the greatest increases in prevalence over time. Increasing disparities over time were identified across all socioeconomic subgroups analyzed including rural compared with urban residence, income, and payer. Key areas of concern include the rate at which substance use disorders rose among rural women and the disproportionate burden of each condition among women from the lowest income communities and among women with Medicaid as their primary payer. CONCLUSION: Between 2005–2006 and 2013–2014, the prevalence of chronic conditions increased across all segments of the childbearing population. Widening disparities were identified over time with key areas of concern including disproportionate, progressive increases in the burden of chronic conditions among women from rural and low-income communities and those with deliveries funded by Medicaid.

5 October 2018 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TWTyler N. A. Winkelman
Tyler N. A. Winkelman
LALindsay K. Admon
Lindsay K. Admon
LJLatasha Jennings
Latasha Jennings
NSNathan D. Shippee
Nathan D. Shippee
CRCaroline R. Richardson
Caroline R. Richardson
GBGavin Bart
Gavin Bart
Largely overshadowed by the opioid epidemic, deaths from psychostimulants increased more than 250% between 2008 and 2015 after a period of declining amphetamine use.1,2 Use of amphetamines, primarily illicit methamphetamine hydrochloride, surged in the early 2000s and then began to decline in the mid-2000s as precursors to methamphetamine production were restricted.3 Coinciding with an uptrend in psychostimulant deaths are increases in the demand and supply of high-purity, low-cost methamphetamine, as the US Drug Enforcement Administration recently reported.1 In some US states, deaths from methamphetamine have surpassed deaths from heroin.4 Preliminary evidence shows that amphetamine-related use of treatment facilities and emergency departments (EDs) has increased in the past several years.5-7 Amphetamine use is now the fourth most common reason to seek drug treatment in the United States, after alcohol, opioid, and marijuana use.5

1 February 2017 in JAMA Pediatrics
Verified
Journal Article
Closed access
PDF file
NVNicole L. G. Villapiano
Nicole L. G. Villapiano
TWTyler N. A. Winkelman
Tyler N. A. Winkelman
KKKaty B. Kozhimannil
Katy B. Kozhimannil
MDMatthew M. Davis
Matthew M. Davis
SPStephen W. Patrick
Stephen W. Patrick
This study uses National Inpatient Sample data to examine national trends in neonatal abstinence syndrome maternal opioid use among rural patients compared with